Stock Yards Bank & Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$893K Sell
3,052
-15
-0.5% -$4.93K 0.03% 225
2025
Q4
$1.08M Sell
3,067
-253
-8% -$85.5K 0.03% 205
2025
Q3
$1.07M Sell
3,320
-616
-16% -$192K 0.03% 207
2025
Q2
$1.53M Sell
3,936
-814
-17% -$327K 0.05% 172
2025
Q1
$2.07M Sell
4,750
-444
-9% -$178K 0.07% 140
2024
Q4
$1.92M Sell
5,194
-221
-4% -$92.5K 0.07% 149
2024
Q3
$2.82M Sell
5,415
-935
-15% -$499K 0.09% 135
2024
Q2
$3.44M Sell
6,350
-529
-8% -$280K 0.11% 117
2024
Q1
$3.57M Sell
6,879
-737
-10% -$367K 0.12% 126
2023
Q4
$3.59M Sell
7,616
-5,340
-41% -$2.47M 0.13% 121
2023
Q3
$5.64M Sell
12,956
-23,182
-64% -$10.5M 0.22% 82
2023
Q2
$16.1M Buy
36,138
+1,525
+4% +$704K 0.59% 51
2023
Q1
$15.9M Buy
34,613
+1,385
+4% +$659K 0.61% 47
2022
Q4
$17M Buy
33,228
+545
+2% +$277K 0.67% 45
2022
Q3
$14.8M Buy
32,683
+2,258
+7% +$1.08M 0.63% 44
2022
Q2
$14.7M Buy
30,425
+3,735
+14% +$1.85M 0.6% 46
2022
Q1
$13.1M Buy
26,690
+4,053
+18% +$1.85M 0.73% 49
2021
Q4
$10.5M Buy
22,637
+21,392
+1,718% +$9M 0.55% 54
2021
Q3
$464K Sell
1,245
-200
-14% -$76K 0.03% 161
2021
Q2
$552K Sell
1,445
-473
-25% -$181K 0.04% 152
2021
Q1
$689K Hold
1,918
0.05% 144
2020
Q4
$616K Hold
1,918
0.04% 149
2020
Q3
$515K Hold
1,918
0.04% 148
2020
Q2
$504K Hold
1,918
0.04% 151
2020
Q1
$435K Sell
1,918
-48
-2% -$13.1K 0.05% 144
2019
Q4
$593K Hold
1,966
0.05% 145
2019
Q3
$472K Sell
1,966
-187
-9% -$51.2K 0.04% 151
2019
Q2
$608K Buy
2,153
+187
+10% +$51.1K 0.06% 141
2019
Q1
$565K Buy
1,966
+7
+0.4% +$2.02K 0.06% 144
2018
Q4
$514K Buy
1,959
+26
+1% +$7.15K 0.06% 140
2018
Q3
$530K Buy
1,933
+20
+1% +$5.19K 0.05% 143
2018
Q2
$455K Sell
1,913
-84
-4% -$19.5K 0.05% 148
2018
Q1
$438K Hold
1,997
0.05% 152
2017
Q4
$449K Hold
1,997
0.05% 146
2017
Q3
$379K Sell
1,997
-178
-8% -$33.9K 0.04% 154
2017
Q2
$409K Sell
2,175
-74
-3% -$13.3K 0.05% 148
2017
Q1
$372K Hold
2,249
0.05% 156
2016
Q4
$323K Hold
2,249
0.04% 160
2016
Q3
$282K Buy
2,249
+182
+9% +$23.5K 0.04% 172
2016
Q2
$271K Sell
2,067
-167
-7% -$22.9K 0.04% 192
2016
Q1
$311K Sell
2,234
-678
-23% -$90.6K 0.04% 168
2015
Q4
$406K Buy
2,912
+94
+3% +$12.9K 0.06% 154
2015
Q3
$395K Sell
2,818
-65
-2% -$9.77K 0.06% 150
2015
Q2
$473K Buy
2,883
+487
+20% +$77.8K 0.07% 147
2015
Q1
$370K Buy
2,396
+36
+2% +$5.13K 0.05% 163
2014
Q4
$297K Sell
2,360
-618
-21% -$76.4K 0.04% 188
2014
Q3
$356K Sell
2,978
-30
-1% -$3.44K 0.05% 166
2014
Q2
$324K Buy
3,008
+8
+0.3% +$824 0.05% 183
2014
Q1
$299K Sell
3,000
-45
-1% -$4.07K 0.04% 185
2013
Q4
$281K Hold
3,045
0.04% 182
2013
Q3
$255K Hold
3,045
0.04% 182
2013
Q2
$249K Buy
+3,045
New +$228K 0.03% 186

Other funds holding ELV

Stock Yards Bank & Trust's ELV Position: Q1 2026 in Review

Stock Yards Bank & Trust reduced its Elevance Health (ELV) stake by 0.49% in Q1 2026, selling an estimated $4.93K and leaving 3,052 shares worth $893K. The position accounts for 0.03% of the portfolio, ranked #225.

Stock Yards Bank & Trust first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $17M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Stock Yards Bank & Trust held 3,052 shares of Elevance Health worth $893K as of Q1 2026.
  • Stock Yards Bank & Trust sold 15 Elevance Health shares in Q1 2026, an estimated $4.93K.
  • Elevance Health made up 0.03% of Stock Yards Bank & Trust's portfolio in Q1 2026, its #225 holding.
  • Stock Yards Bank & Trust first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Stock Yards Bank & Trust's Elevance Health position peaked at $17M in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Stock Yards Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.